Breakthrough Cooperation of Legend Capital's Cross-border Po

HONG KONG, June 15, 2022 - (ACN Newswire) - On June 14, two of Legend Capital's portfolio companies, Innovent Biologics, Inc. ("Innovent") and PT Etana Biotechnologies Indonesia ("Etana"), jointly announced

Related Keywords

China , Indonesia , Indonesian , Chinese , Innovent Biologics , Frank Hong , Nathan Tirtana , Fei Qi , Exegenesis Bio , Michael Yu , Innostellar Biotherapeutics , Recbio Technology , Kawin Technology , Drugs Authority , Lynk Pharmaceuticals , Innovent Biologics Inc , Business Development , Legend Capital , Biotechnologies Indonesia , Indonesian Food , President Director , Southeast Asian , Managing Director , Executive Director , Southeast Asia , Glubio Pharmaceutical , Ribo Life Science , Breakthrough , Cooperation , Legend , Capital , Cross , Order , Portfolio , Companies , Innovent , Astana , Ointly , Nnounce , Approval , Prevagen , Pom ,